Aggressive Surgery Improves Long-term Survival in Neuroendocrine Pancreatic Tumors
- 1 February 2007
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 245 (2) , 273-281
- https://doi.org/10.1097/01.sla.0000232556.24258.68
Abstract
Objective: To evaluate surgical strategies for neuroendocrine pancreatic tumors (NEPT) in the light of the new WHO classification from 2004 and to draw conclusions for future surgical concepts. Background: The extent of surgical resection in primary and recurrent NEPT is unclear. Methods: Between 1987 and 2004, 62 patients with sporadic NEPT were treated at our institution and sections from biopsy and resection specimen were histopathologically reclassified. Clinical presentation, surgery, metastases, and pattern of recurrence were related to survival. Results: Fifteen well-differentiated tumors (WDT, 24%), 39 low-grade carcinomas (LGC, 63%), and 8 high-grade carcinomas (HGC, 13%) were identified. Median observation time was 30.5 months; 48 of 62 patients (78%) were surgically resected, and in 45 patients R0/R1 status was achieved. Overall 2- and 5-year survival in the latter group was 80% and 64%, respectively. Retrospective WHO classification revealed that organ-preserving segmental resections had been performed in 10 LGC and 1 HGC. These patients showed equal outcome as radically resected counterparts (n = 19). Liver and other organ metastases were present in 19 of 62 patients (31%), and resection was accomplished in 7 of 19 patients, which conferred better overall survival (P = 0.026, log-rank test); 21 of 45 R0/R1-resected patients (47%) suffered from recurrence, and reoperation was accomplished in 9 patients, which resulted in better overall survival (P = 0.066). Conclusion: Organ-preserving resections offer sufficient local control in LGC; therefore, radical resections do not seem to be justified. On the other hand, radical resection is indicated even in metastasized patients or in case of loco-regional recurrence. The silent and slow course of the disease facilitates long-term surgical control.Keywords
This publication has 23 references indexed in Scilit:
- Neuroendocrine tumour management: a team approachBritish Journal of Hospital Medicine, 2005
- The surgical management of MEN-1 pancreatoduodenal neuroendocrine diseaseSurgery, 2004
- Surgery of Resectable Nonfunctioning Neuroendocrine Pancreatic TumorsWorld Journal of Surgery, 2004
- Survival and Clinical Outcome of Patients with Neuroendocrine Tumors of the Gastroenteropancreatic Tract in a German Referral CenterAnnals of the New York Academy of Sciences, 2004
- Aggressive surgery for metastatic liver neuroendocrine tumorsSurgery, 2003
- Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumorsArchives of Surgery, 2003
- Laparoscopy Predicts Metastatic Disease and Spares Laparotomy in Selected Patients With Pancreatic Nonfunctioning Islet Cell TumorsAnnals of Surgical Oncology, 2001
- Revised classification of neuroendocrine tumours of the lung, pancreas and gutVirchows Archiv, 1995
- Chromogranins — New Sensitive Markers for Neuroendocrine TumorsActa Oncologica, 1989
- Neuroendocrine Pancreatic Tumors Clinical Findings in a prospective study of 84 patientsActa Oncologica, 1989